tiprankstipranks
Spero Therapeutics (SPRO)
NASDAQ:SPRO
US Market
SPRO
Spero Therapeutics
RESEARCH TOOLSreports
Want to see SPRO full AI Analyst Report?

Spero Therapeutics (SPRO) Ratios

585 Followers

Spero Therapeutics Ratios

SPRO's free cash flow for Q4 2025 was $1.00. For the 2025 fiscal year, SPRO's free cash flow was decreased by $ and operating cash flow was $0.75. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 7.59 7.59 2.19 3.53 5.04
Quick Ratio
 7.59 7.59 2.19 3.53 5.25
Cash Ratio
 4.54 4.54 1.08 2.05 5.04
Solvency Ratio
 0.87 0.87 -1.06 0.31 -0.93
Operating Cash Flow Ratio
 -1.42 -1.42 -0.48 -0.89 -0.36
Short-Term Operating Cash Flow Coverage
 -6.45 -6.45 0.00 -19.21 0.00
Net Current Asset Value
$ 57.39M$ 57.39M$ 42.86M$ 55.71M$ 60.24M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.04 0.03 0.05
Debt-to-Equity Ratio
 0.05 0.05 0.09 0.05 0.09
Debt-to-Capital Ratio
 0.05 0.05 0.09 0.05 0.08
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.17 1.17 2.40 1.71 1.64
Debt Service Coverage Ratio
 2.66 -0.15 0.00 14.29 -16.48
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -16.20
Debt to Market Cap
 0.01 0.01 0.00 0.02 0.00
Interest Debt Per Share
 0.05 0.05 0.08 0.11 0.25
Net Debt to EBITDA
 -6.83 1.56K 0.67 -2.61 2.39
Profitability Margins
Gross Profit Margin
77.47%100.00%-101.67%50.43%100.00%
EBIT Margin
9.05%-0.04%-151.08%25.81%-90.18%
EBITDA Margin
9.05%-0.04%-151.08%26.16%-88.39%
Operating Profit Margin
-0.04%-0.04%-152.91%20.70%-86.86%
Pretax Profit Margin
14.63%14.82%-142.91%24.48%-95.55%
Net Profit Margin
14.20%14.38%-142.91%21.98%-95.55%
Continuous Operations Profit Margin
14.20%14.38%-142.91%21.98%-95.55%
Net Income Per EBT
97.05%97.05%100.00%89.77%100.00%
EBT Per EBIT
-36804.17%-36804.17%93.46%118.26%110.00%
Return on Assets (ROA)
12.44%12.44%-62.03%12.50%-37.19%
Return on Equity (ROE)
22.53%14.52%-148.66%21.34%-61.13%
Return on Capital Employed (ROCE)
-0.04%-0.04%-119.35%14.79%-40.91%
Return on Invested Capital (ROIC)
-0.04%-0.04%-116.05%13.12%-40.25%
Return on Tangible Assets
12.44%12.44%-62.03%12.50%-37.19%
Earnings Yield
6.12%6.57%-123.19%29.44%-71.38%
Efficiency Ratios
Receivables Turnover
 2.38 2.35 0.91 2.05 44.81
Payables Turnover
 19.63 0.00 13.24 37.33 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 40.80 40.28 15.41 24.97 8.85
Asset Turnover
 0.88 0.87 0.43 0.57 0.39
Working Capital Turnover Ratio
 1.24 1.02 0.63 1.14 0.43
Cash Conversion Cycle
 134.87 155.42 371.67 168.52 8.14
Days of Sales Outstanding
 153.46 155.42 399.23 178.30 8.14
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 18.59 0.00 27.56 9.78 0.00
Operating Cycle
 153.46 155.42 399.23 178.30 8.14
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.23 -0.23 -0.43 -0.63 -0.21
Free Cash Flow Per Share
 -0.23 -0.23 -0.43 -0.63 -0.21
CapEx Per Share
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -4.36 -4.36 -5.46 -5.95 -1.16
Operating Cash Flow to Sales Ratio
 -0.21 -0.21 -0.49 -0.32 -0.16
Free Cash Flow Yield
-8.72%-9.67%-42.12%-42.59%-11.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 16.40 15.23 -0.81 3.40 -1.40
Price-to-Sales (P/S) Ratio
 2.41 2.19 1.16 0.75 1.34
Price-to-Book (P/B) Ratio
 2.38 2.21 1.21 0.72 0.86
Price-to-Free Cash Flow (P/FCF) Ratio
 -11.51 -10.34 -2.37 -2.35 -8.41
Price-to-Operating Cash Flow Ratio
 -11.14 -10.34 -2.37 -2.35 -8.41
Price-to-Earnings Growth (PEG) Ratio
 0.07 -0.14 <0.01 -0.03 0.02
Price-to-Fair Value
 2.38 2.21 1.21 0.72 0.86
Enterprise Value Multiple
 19.74 -3.88K -0.10 0.25 0.87
Enterprise Value
 107.36M 93.16M 7.07M 6.68M -37.44M
EV to EBITDA
 19.64 -3.88K -0.10 0.25 0.87
EV to Sales
 1.78 1.56 0.15 0.06 -0.77
EV to Free Cash Flow
 -8.50 -7.38 -0.30 -0.20 4.84
EV to Operating Cash Flow
 -8.50 -7.38 -0.30 -0.20 4.84
Tangible Book Value Per Share
 1.05 1.05 0.85 2.03 2.02
Shareholders’ Equity Per Share
 1.05 1.05 0.85 2.03 2.02
Tax and Other Ratios
Effective Tax Rate
 0.03 0.03 0.00 0.10 0.00
Revenue Per Share
 1.08 1.06 0.89 1.97 1.29
Net Income Per Share
 0.15 0.15 -1.27 0.43 -1.23
Tax Burden
 0.97 0.97 1.00 0.90 1.00
Interest Burden
 1.62 -368.04 0.95 0.95 1.06
Research & Development to Revenue
 0.64 0.65 2.02 0.50 0.98
SG&A to Revenue
 0.35 0.36 0.49 0.24 0.75
Stock-Based Compensation to Revenue
 0.07 0.07 0.16 0.08 0.00
Income Quality
 -1.47 -1.47 0.34 -1.45 0.17
Currency in USD